Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Examining how psychotherapy affects paranoia in schizophrenia

Official title: Testing the Role of Belief Updating in Persecutory Delusions

Run by Vanderbilt University Medical Center · NCT06835556 · Data updated 2026-11-12

This study is testing whether psychotherapy can help people with schizophrenia feel less paranoid and change how they think about their surroundings.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment120 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedJanuary 15, 2025
Main results expectedSeptember 3, 2029
Study endsFebruary 1, 2030
Registry record updatedSeptember 30, 2026
Trial IDNCT06835556 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include men and women aged 18 to 65 with a diagnosis of a non-affective psychotic disorder and persistent persecutory delusions.

Probably not a fit

Patients with serious medical or neurological illnesses that interfere with cognitive functioning may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of psychotherapy on individuals with schizophrenia-spectrum disorders, specifically focusing on changes in belief updating and environmental volatility related to persecutory delusions. Participants will receive either Cognitive Behavioral Therapy for psychosis (CBTp) or treatment as usual (TAU) along with phone check-ins over a 16-week period. Assessments will be conducted at four different time points over six months, and MRI scans may be performed to observe corresponding brain activity changes. The study aims to determine if effective treatment can reduce prior expectations about environmental volatility and alter brain activity.

Why it matters

Potential benefit: If successful, this study could lead to improved therapeutic strategies for managing paranoia in patients with schizophrenia.

How similar studies have gone: Previous studies have shown promise in using psychotherapy to address delusions in schizophrenia, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women age 18 - 65.
* Communicative in English.
* Premorbid IQ \>79 (WTAR)
* Provide voluntary, written informed consent.
* Stable medication regimen over at least the past two weeks, including the use of either an oral or intramuscular administration of an antipsychotic medication.
* Diagnosis of a non-affective psychotic disorder (e.g. schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder)
* A persecutory delusion scoring at least a 3 on the conviction scale of the Psychotic Symptoms Rating Scale (PSYRATS) that had persisted for at least two months and that was not considered the direct result of substance use.

Exclusion Criteria:

* Serious medical or neurological illness known to interfere with cognitive functioning (uncontrolled/unstable diabetes, uncontrolled hypothyroidism, Cushing's disease, Lupus, any demyelinating disease such as Multiple Sclerosis, HIV infection, CNS infection, unstable heart disease, active hepatitis, other significant endocrine condition, any cancer involving the CNS/brain, any uncorrected vision problems, tardive dyskinesia).
* History of severe head trauma with loss of consciousness \>30 minutes.
* Primary diagnosis of alcohol or substance use disorder or personality disorder

Where it's running

  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.